RxDoctor Payments Data

Kimberly Paris, APRN

Family · Suwanee, GANPI 1144756255

Payments from drug & device makers

$6,238in general payments, 2019–2025

Across 361 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$917
  • Paratek Pharmaceuticals, Inc.$889
  • Takeda Pharmaceuticals U.S.A., Inc.$868
  • Gilead$860
  • Melinta Therapeutics, LLC$679
  • Merck$318
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$6,17399%
  • Education$651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,238 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$26,180
Medicare patients
38
Services billed
1,756

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala38$156,475
GenvoyaElviteg/Cob/Emtri/Tenof Alafen24$108,931
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf11$85,523
ErtapenemErtapenem Sodium13$14,685
ValacyclovirValacyclovir Hcl28$2,437
Doxycycline Hyclate64$2,031
Nystatin13$728
Fluconazole23$553
Sodium Chloride0.9 % Sodium Chloride21$535
Liothyronine Sodium11$389
Cefdinir21$382
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$311
Levothyroxine Sodium13$270
Albuterol Sulfate HfaAlbuterol Sulfate12$190
Ondansetron Hcl23$175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya$860$265,40662 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.

Other family in Suwanee

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →